Our spinouts

IR Pharma

IR Pharma provides the pharmaceutical industry with Respiratory Pharmacology pre-clinical drug discovery through short, focused projects and larger, wide ranging system-based discovery programmes.

Timely delivery of study objectives that add value to client lead compounds and technology are a high priority for the company. Based on the world leading academic expertise of the Respiratory Pharmacology group at the National Heart and Lung Institute, Imperial College, led by Professor Maria Belvisi and Dr Mark Birrell, the team, in addition, boasts an extensive industry background.